Foresight Diagnostics reposted this
#ForesightDx, in collaboration with Memorial Sloan Kettering Cancer Center (MSK) and Stanford University School of Medicine, is pleased to present new data showcasing Foresight CLARITY™ ultra-sensitive MRD detection in early-stage breast cancer at the ESMO Congress 2024. Poster 293: "Ultra-sensitive ctDNA detection and monitoring in early breast cancer using PhasED-Seq™" “The ability to study MRD in early-stage breast cancer has often been limited by assay sensitivity,” said Dr. David Kurtz, Chief Medical Officer and Head of Research at Foresight. “The results from this study point to Foresight CLARITY as a promising tool to advance research in novel personalized treatment strategies. We look forward to presenting our findings at the upcoming ESMO Congress.” Read Press Release Here: https://t.ly/gJg4r For more information, please attend our poster session (details in Press Release) or schedule to meet with our team here: Email: BD@foresight-dx.com Online: https://lnkd.in/eSisfcab #ESMO24 #MRD #ctDNA #MSK #BreastCancer #oncology #PrecisionMedicine
